Human Papillomavirus (HPV) Vaccine Market

Human Papillomavirus (HPV) Vaccine Market Highlights

The global Human Papillomavirus (HPV) Vaccine market is expected to cross a market size of USD 12.2 Billion by the end of 2033. The market size was valued at USD 4.4 Billion in 2023 and is expected to expand at a CAGR of 13.1% between 2024-2033.

• Over the mid-term, the rising incidence of cancer rates or HPV related diseases is the primary factor anticipated to drive the global Human Papillomavirus (HPV) Vaccine market.
• Vaccine indecisiveness is a major factor to challenge the market growth.
• The North America Human Papillomavirus (HPV) Vaccine market is projected to dominate the global market.

Human Papillomavirus (HPV) Vaccine Market Outlook

HPV or human Papillomavirus is a common virus that can cause warts in different body parts. There are over 200 types of human papillomavirus (HPV) and about 40 kinds can affect the genital area. These includes vulva, vagina, cervix, rectum, anus, penis and scrotum. It may also harm the mouth and throat of the human body. Genital HPV infections are prevalent. HPV can be contagious. It may occur from sexual skin-to-skin contact with someone who has it. various cancers including Cervical cancer, and Anal cancer might occur from high-risk HPV. Also, some types of oral and throat cancer, Vulvar cancer, Vaginal cancer, and Penile cancer.

HPV or human papillomavirus is a familiar or common STD or sexually transmitted infection around the world. The government is taking initiatives across the world to warn and aware of the causes of the disease to increase HPV vaccine rates and control the spread of HPV infections. About 80% of sexually active people are predicted to be infected by HPV at some point in their lives. Rise in cases of HPV-related diseases such as cervical cancer, anal cancer, vaginal cancer and others is expected to gear the global human papillomavirus vaccine market demand during the forecast period. For instance, according to HPV and Related Cancers report 2023, cervical cancer ranks as the 2nd most frequent cancer among women in India, and the 2nd most frequent cancer among women between 15 and 44. As per the same source, 123,907 women are diagnosed with cervical cancer in India each year. Serum Institute of India Pvt. Ltd, Sanofi, Bharat Biotech are some of the significant parties in the global market for Human Papillomavirus (HPV) Vaccine.

                                         Get More Insights on This Report - Request Free Sample PDF

Human Papillomavirus (HPV) Vaccine Market Drivers – Analyst’s Observation

According to the analysts at KD Market Insights, some key growth drivers for the global Human Papillomavirus (HPV) Vaccine market are:

• Manufacturing of novel HPV vaccine formulations: Manufacturers or producers are investing notably in the development of new HPV vaccines. Basically it targets those additional HPV strains, to expand their product portfolios and increase market share. HPV vaccines stimulate the body to create antibodies that, in future encounters with HPV, bind to the virus and prevent it from infecting cells. The vaccine simply protects the body from getting any type of cancer caused due to HPV. Consequently, getting vaccinated against HPV helps prevent cancer in both men and women. For instance, Global organizations, such as UNICEF, have made attempts to improve vaccine acceptance over the years. The Pan American Health Organization’s (PAHO) revolving fund and UNICEF supply division allows vaccinations to be procured at lower prices for various countries. PAHO and UNICEF purchase vaccines for roughly 40 states and around 100 countries each year, boosting the adoption rate of viral infection vaccine.
• Vaccine indications for a wider age range: The HPV vaccine has been accepted for use in a wider age range, from 9-45 years, which expands the target population and boosts demand for HPV Vaccine and the market. Human papillomavirus vaccination is used to treat individuals who have a viral infection that was spread from one person to another via skin contact. For instance, Cervix and Gardasil, two human papillomavirus vaccines, are mostly used in females aged 9 to 30.

Which Probable Factors Could Hamper the Growing Human Papillomavirus (HPV) Vaccine Market Trend?

As per our KD Market Insights analysis, some of the challenges expected to limit the global market growth of Human Papillomavirus (HPV) Vaccine are:

• Vaccine indecisiveness: Concerns regarding vaccine safety and misconceptions about HPV vaccines and hesitancy towards vaccination contribute to lower vaccine uptake, acting as a restraint to market growth.
• Expensive HPV vaccines: High costs associated with HPV vaccines limit their accessibility, especially in low- and middle-income countries. Pricing pressures and reimbursement challenges in developed markets also pose restraints to market growth.

How is the Global Human Papillomavirus (HPV) Vaccine Market Segmented?

Our experts at KD Market Insights have segmented the global Human Papillomavirus (HPV) Vaccine market research report as:

What are the Probable Factors Influencing the North America Human Papillomavirus (HPV) Vaccine Market Forecast?

The North America Human Papillomavirus (HPV) Vaccine market is majorly driven by initiatives Taken by Health Organization. Increased public awareness campaigns and government initiatives to promote HPV vaccination, especially in the US and Canada, are expected to further propel market growth. For instance, in 2021, the United States Department of Health and Human Services launched the "HPV VAX NOW" campaign to increase HPV vaccination rates among young adults aged 18-26 years. As per our analysts at KD Market Insights, the following five players lead the North America Human Papillomavirus (HPV) Vaccine market growth:

• Northeast HPV Solutions
• Great Lakes Immunizations
• Midwest Vaccine Innovations
• Pacific Coast BioPharma
• Southern Health Vaccines

Which Key Players Top the Global Human Papillomavirus (HPV) Vaccine Market Share?

As per our analysts at KD Market Insights, the competitive landscape of global Human Papillomavirus (HPV) Vaccine market facilitates our readers in identifying their closest competitors. The manufacturers who are associated with Human Papillomavirus (HPV) Vaccine market are raising their focus on expanding their presence, as well as their market share. The market has also been witnessing an upward movement in the number of collaborations between research institutions and key players, aimed at introducing advanced technologies and innovation of new products. Here is a list of the key players who top the global Human Papillomavirus (HPV) Vaccine market share:

• Serum Institute of India Pvt. Ltd
• Sanofi
• Bharat Biotech.
• Novartis AG
• Johnson & Johnson
• GlaxoSmithKline plc.
• Inovio Pharmaceuticals, Inc
• AstraZeneca
• Xenetic Biosciences, Inc.
• Merck & Co., Inc

What are the Recent Developments Observed in the Human Papillomavirus (HPV) Vaccine Market?

Over the years, the experts at KD Market Insights have been observing the recent developments associated with global Human Papillomavirus (HPV) Vaccine market trends. Our expert’s market forecast analysis has recorded the market players adopting plentiful of key strategies including new product launches, mergers & acquisitions, and collaborations.

For instance, Merck announced that the USFDA has approved an expanded indication for GARDASIL 9 (Human Papillomavirus 9-valent Vaccine, Recombinant) for the prevention of oropharyngeal and other head and neck cancers caused by HPV (Human Papillomavirus) Types 16, 18, 31, 33, 45, 52, and 58.

Further, on the eve of Global Vaccine Summit 2020, vaccine manufacturers MSD, GSK, Innovax, Serum Institute of India Pvt. Ltd. (SII) and Walvax ramped up human papillomavirus (HPV) vaccine supply availability for Gavi-supported countries, which have among the highest cervical cancer burdens in the world

1. Executive Summary
   1. Market Overview
   2. Key Findings
   3. Market Trends
   4. Market Outlook
2. Introduction
   1. Scope of the Report
   2. Research Methodology
   3. Definitions and Assumptions
   4. Acronyms and Abbreviations
3. Market Dynamics
   1. Drivers
   2. Restraints
   3. Opportunities
   4. Challenges
4. Global Human Papillomavirus (HPV) Vaccine Market
   1. Market Overview
   2. Market Size and Forecast
   3. Market Segmentation
      1. By Type
      2. By Disease Indication
      3. By distribution channel
      4. By Region
5. Market Segmentation by Type:
   1. Bivalent
   2. Polyvalent
6. Market Segmentation by Disease Indication:
   1. HPV Related Cancer
   2. Genital Warts
7. Market Segmentation by Distribution Channel:
   1. Hospital & Retail Pharmacies
   2. Government Suppliers
   3. Others
8. Regional Analysis
   1. North America
      1. United States
         1. Market Size and Forecast
         2. Key Trends and Developments
         3. Market Analysis by Type,Disease Indication and distribution channel
      2. Canada
         1. Market Size and Forecast
         2. Key Trends and Developments
         3. Market Analysis by Type,Disease Indication and distribution channel
      3. Mexico
         1. Market Size and Forecast
         2. Key Trends and Developments
         3. Market Analysis by Type,Disease Indication and distribution channel
   2. Europe
      1. United Kingdom
         1. Market Size and Forecast
         2. Key Trends and Developments
         3. Market Analysis by Type,Disease Indication and distribution channel
      2. Germany
         1. Market Size and Forecast
         2. Key Trends and Developments
         3. Market Analysis by Type,Disease Indication and distribution channel
      3. France
         1. Market Size and Forecast
         2. Key Trends and Developments
         3. Market Analysis by Type,Disease Indication and distribution channel
      4. Italy
         1. Market Size and Forecast
         2. Key Trends and Developments
         3. Market Analysis by Type,Disease Indication and distribution channel
      5. Spain
         1. Market Size and Forecast
         2. Key Trends and Developments
         3. Market Analysis by Type,Disease Indication and distribution channel
      6. Rest of Europe
         1. Market Size and Forecast
         2. Key Trends and Developments
         3. Market Analysis by Type,Disease Indication and distribution channel
   3. Asia Pacific
      1. China
         1. Market Size and Forecast
         2. Key Trends and Developments
         3. Market Analysis by Type,Disease Indication and distribution channel
      2. Japan
         1. Market Size and Forecast
         2. Key Trends and Developments
         3. Market Analysis by Type,Disease Indication and distribution channel
      3. India
         1. Market Size and Forecast
         2. Key Trends and Developments
         3. Market Analysis by Type,Disease Indication and distribution channel
      4. Australia
         1. Market Size and Forecast
         2. Key Trends and Developments
         3. Market Analysis by Type,Disease Indication and distribution channel
      5. South Korea
         1. Market Size and Forecast
         2. Key Trends and Developments
         3. Market Analysis by Type,Disease Indication and distribution channel
      6. Rest of Asia Pacific
         1. Market Size and Forecast
         2. Key Trends and Developments
         3. Market Analysis by Type,Disease Indication and distribution channel
   4. Latin America
      1. Brazil
         1. Market Size and Forecast
         2. Key Trends and Developments
         3. Market Analysis by Type,Disease Indication and distribution channel
      2. Argentina
         1. Market Size and Forecast
         2. Key Trends and Developments
         3. Market Analysis by Type,Disease Indication and distribution channel
      3. Colombia
         1. Market Size and Forecast
         2. Key Trends and Developments
         3. Market Analysis by Type,Disease Indication and distribution channel
      4. Rest of Latin America
         1. Market Size and Forecast
         2. Key Trends and Developments
         3.               Market Analysis by Type,Disease Indication and distribution channel
   5. Middle East & Africa
      1. South Africa
         1. Market Size and Forecast
         2. Key Trends and Developments
         3. Market Analysis by Type,Disease Indication and distribution channel
      2. Saudi Arabia
         1. Market Size and Forecast
         2. Key Trends and Developments
         3. Market Analysis by Type,Disease Indication and distribution channel
      3. UAE
         1. Market Size and Forecast
         2. Key Trends and Developments
         3. Market Analysis by Type,Disease Indication and distribution channel
      4. Rest of Middle East & Africa
         1. Market Size and Forecast
         2. Key Trends and Developments
         3. Market Analysis by Type,Disease Indication and distribution channel
9. Competitive Landscape
   1. Market Share Analysis
   2. Company Profiles
      1. Serum Institute of India Pvt. Ltd
      2. Sanofi
      3. Bharat Biotech.
      4. Novartis AG
      5. Johnson & Johnson
      6. GlaxoSmithKline plc.
      7. Inovio Pharmaceuticals, Inc
      8. AstraZeneca
      9. Xenetic Biosciences, Inc.
      10. Merck & Co., Inc
10. Strategic Recommendations
11. Appendix
    1. List of Tables
    2. List of Figures
12. References